about
Unraveling the complex story of immune responses to AAV vectors trial after trial.Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments.Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion.Prostaglandin terminal synthases as novel therapeutic targets.Differential Expression of Sox11 and Bdnf mRNA Isoforms in the Injured and Regenerating Nervous Systems.A novel and high efficient AAV6 mutant.
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
AAV: An Overview of Unanswered Questions.
@en
AAV: An Overview of Unanswered Questions.
@nl
type
label
AAV: An Overview of Unanswered Questions.
@en
AAV: An Overview of Unanswered Questions.
@nl
prefLabel
AAV: An Overview of Unanswered Questions.
@en
AAV: An Overview of Unanswered Questions.
@nl
P2860
P356
P1433
P1476
AAV: An Overview of Unanswered Questions.
@en
P2093
Kenneth I Berns
Nicholas Muzyczka
P2860
P304
P356
10.1089/HUM.2017.048
P577
2017-04-01T00:00:00Z